Americas Companion Animal Healthcare Market, by Diagnostics, 2018-2027

Growth Outlook

• The 2027 portion of the Americas Companion Animal Healthcare Market, by Diagnostics, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 1838 Mn in 2026 and is projected to reach USD 1971 Mn by 2027 — a gain of about 7% over the forecast period, translating to a CAGR in the high single digits.
• 2027: Others leads this comparison at 602. 38M USD — 31% of the combined total across all 4 groups shown.
• What the regional split looks like (2026): Others leads, holding roughly 31% of segment value — the single largest regional share. Diagnostic Imaging is the second-largest contributor. Immunodiagnostic Tests and Molecular Diagnostics make up the remainder, in descending order.
• By 2027, Others alone is expected to reach USD 602 Mn, with Diagnostic Imaging at USD 558 Mn.

Market Dynamics

2027: Others leads this comparison at 602.38M USD — 31% of the combined total across all 4 groups shown.

Next is Diagnostic Imaging, at 557.61M USD — 7% behind Others.

Others: 348.40M USD in 2018 to 602.38M USD by 2027, up 73%.

Diagnostic Imaging: up 64% over the period, 340.54M USD to 557.61M USD.

Immunodiagnostic Tests climbs from 269.95M USD (2018) to 510.52M USD (2027), a 89% gain.

Molecular Diagnostics: 180.39M USD to 300.89M USD, 67% higher by 2027.

The fastest mover is Immunodiagnostic Tests, up 89% over the period — a steeper climb than any of the other 4 groups here.

Combined, all 4 groups add up to 1.97B USD by 2027 — 73% up from 1.14B USD in 2018.

Reading A Multi-Series Chart

This chart compares 4 series side by side, not one trend over time. Read them against each other — the biggest number in the room is not automatically the most important line to follow.

The largest series today is not guaranteed to stay largest — check the growth rate of each group, not just its current size, before projecting the ranking forward.

Use this chart to size the Americas Companion Animal Healthcare market and to compare how fast it is expected to grow against adjacent markets — it works best as an input to a market-entry or investment decision, not as a standalone verdict.

The numbers here come from a market sizing model: historical revenue estimates up to the 2018 base year, then forecasts through 2027 using growth-rate assumptions for each segment. The underlying report explains the methodology in detail.